We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

EMIS:NASDAQEmmis Acquisition Corp. Analysis

Data as of 2026-03-31 - not real-time

$10.03

Latest Price

7/10Risk

Risk Level: Medium

Executive Summary

EMIS trades at a staggering price‑to‑book of 125.4, far above typical equity valuations, while reporting zero revenue, earnings, and cash flow, indicating a pure SPAC structure with no operating fundamentals. The technical picture is neutral: the 20‑day, 50‑day and 200‑day SMAs are virtually flat at ~10.04, the RSI sits at 49 (mid‑range), and the MACD histogram is slightly negative, signalling a modest bearish tilt. Support sits just above $10.01 and resistance near $10.08, leaving the current price of $10.03 perched in a narrow band with limited upside. Volume, although flagged as “increasing,” remains microscopic (average 5,230 shares versus a daily volume of 3), creating a pronounced liquidity constraint. Combined with an ultra‑low beta (0.01) and modest 30‑day volatility of 2.2%, the stock exhibits market‑neutral price movement but heightened execution risk due to its thin trading profile.
Given the absence of earnings, dividends, and any disclosed business activity, the valuation appears dramatically over‑inflated relative to intrinsic worth. The “Greed” sentiment in the fear‑greed index (71.9) is not supported by fundamental drivers, and the lack of dividend history makes any yield expectation unsustainable. Investors should therefore treat EMIS as a high‑risk speculative play, with short‑term price action driven more by market sentiment and SPAC‑related news than by underlying performance.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 5/10

Key Factors

  • Bearish MACD histogram
  • Extremely thin trading volume
  • Price trapped between tight support and resistance

Medium Term

1–3 years
Neutral
Model confidence: 4/10

Key Factors

  • No operating revenue or earnings
  • Overstretched price‑to‑book ratio
  • Uncertainty around SPAC merger outcome

Long Term

> 3 years
Cautious
Model confidence: 8/10

Key Factors

  • Fundamental void (zero cash flow, earnings, dividends)
  • High valuation relative to book value
  • Liquidity risk from negligible daily volume

Key Metrics & Analysis

Financial Health

P/B Ratio125.4

Technical Analysis

TrendNeutral
RSI49.0
Support$10.01
Resistance$10.08
MA 20$10.04
MA 50$10.04
MA 200$10.00
MACDBearish
VolumeIncreasing
Fear & Greed Index71.95

Valuation

GradeOvervalued
TypeValue

Risk Assessment

Beta0.01
Volatility2.20%
Sector RiskMedium
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskHigh

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.